BackInspire Medical Systems Overview
Inspire Medical Systems Inc

Inspire Medical Systems Target Price

Analysts' average 12-month price target for Inspire Medical Systems is $57.

Get informed when a big investor buys or sells

+ Follow

Share Price

$63.08

Average Target Price

$57.009.6% downside

11 analysts in the last 4 months

High: $85 | Low: $39

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Evercore ISI$5414.4% downsideOpen
2026-08-04Truist Financial$621.7% downsideOpen
2026-08-04RBC CapitalShagun Singh$604.9% downsideOpen
2026-08-04Stifel Nicolaus$7518.9% upsideOpen
2026-08-04Oppenheimer$8534.7% upsideOpen
2026-08-04Piper Sandler$604.9% downsideOpen
2026-08-04Robert W. Baird$596.5% downsideOpen
2026-07-28UBSPatrick Wood$3938.2% downsideOpen
2026-07-16Truist Financial$5414.4% downsideOpen
2026-06-23Evercore ISIDaniel Markowitz$4036.6% downsideOpen
2026-05-22Summit Redstone Partners$3938.2% downsideOpen
2026-05-05Truist FinancialRichard Newitter$5020.7% downsideOpen
2026-05-05RBC Capital$4528.7% downsideOpen
2026-05-05Evercore ISI$5512.8% downsideOpen
2026-05-05Robert W. BairdDavid Rescott$5020.7% downsideOpen
2026-05-05Piper SandlerAdam Maeder$5512.8% downsideOpen
2026-04-15Truist Financial$641.5% upsideOpen
2026-04-14RBC CapitalShagun Singh$5611.2% downsideOpen
2026-04-13Mizuho Securities$7011% upsideOpen
2026-04-10Stifel Nicolaus$7011% upsideOpen
2026-03-05Stifel NicolausJonathan Block$8534.7% upsideOpen
2026-02-18Morgan Stanley$604.9% downsideOpen
2026-02-13UBS$676.2% upsideOpen
2026-02-12RBC Capital$687.8% upsideOpen
2026-02-12Stifel Nicolaus$9550.6% upsideOpen
2026-02-12Piper Sandler$8534.7% upsideOpen
2026-02-12Mizuho Securities$8534.7% upsideOpen
2026-02-12Wells Fargo$7011% upsideOpen
2026-02-12Robert W. Baird$7417.3% upsideOpen
2026-01-27RBC Capital$9042.7% upsideOpen
2026-01-22UBS$9652.2% upsideOpen
2026-01-22Truist FinancialRichard Newitter$9652.2% upsideOpen
2026-01-22Evercore ISIDaniel Markowitz$12598.2% upsideOpen
2026-01-14Wells Fargo$145129.9% upsideOpen
2026-01-08Truist FinancialRichard Newitter$12090.2% upsideOpen
2025-12-23UBSDanielle Antalffy$9144.3% upsideOpen
2025-12-17RBC Capital$175177.4% upsideOpen
2025-12-17Mizuho Securities$130106.1% upsideOpen
2025-12-08Oppenheimer$175177.4% upsideOpen
2025-12-08Piper Sandler$165161.6% upsideOpen
2025-12-04Robert W. Baird$180185.4% upsideOpen
2025-12-02Morgan Stanley$130106.1% upsideOpen
2025-11-25Truist Financial$165161.6% upsideOpen
2025-11-25Wolfe Research$180185.4% upsideOpen
2025-11-24Truist Financial$128102.9% upsideOpen
2025-11-24Stifel NicolausJonathan Block$11074.4% upsideOpen
2025-11-04RBC Capital$12598.2% upsideOpen
2025-11-04Piper SandlerGAAP EPS$135114% upsideOpen
2025-11-04Mizuho SecuritiesAnthony Petrone$11074.4% upsideOpen
2025-11-04Wells FargoLawrence Biegelsen$9042.7% upsideOpen

Inspire Medical Systems (INSP) FAQ

Inspire Medical Systems (INSP) currently reports a target price of $57. Use the charts on this page to explore Inspire Medical Systems's target price history and peer comparisons.

Analysts' average 12-month price target for Inspire Medical Systems is $57, about 9.6% downside from the current share price of $63.08. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $57, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Inspire Medical Systems, and consider following INSP for alerts when major investors trade the stock.

Inspire Medical Systems is classified in the Healthcare sector. On target price, it currently shows $57. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INSP with unrelated industries.